Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1988-5-26
|
pubmed:abstractText |
Serotonergic and adrenergic receptors in brain areas of the alcohol-preferring P and alcohol-nonpreferring NP rats were compared by radioligand-binding assays. Binding of 3H-serotonin (3H-5HT) to 5HT-1 receptors in membranes of cerebral cortex and hippocampus was significantly higher in density (B max values) and affinity (Kd values) in the P than in the NP rats, whereas B max values in membranes from the brain stem of the P rats were lower than those of the NP rats. No significant difference between the P and NP lines was observed when the binding of 3H-ketanserin to 5HT-2 receptors and of 3H-WB4101, 3H-clonidine and 3H-dihydoalprenolol to alpha-1, alpha-2 and beta-adrenergic receptors was compared. The increase of 3H-5HT binding probably indicates up-regulation or supersensitivity of 5HT-1 receptors as a compensatory mechanism to the lower levels of 5HT in brain areas of the P rats (Murphy, et al., 1982).
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0300-9564
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
71
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
207-18
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:3356985-Alcoholism,
pubmed-meshheading:3356985-Animals,
pubmed-meshheading:3356985-Brain,
pubmed-meshheading:3356985-Brain Stem,
pubmed-meshheading:3356985-Cerebral Cortex,
pubmed-meshheading:3356985-Hippocampus,
pubmed-meshheading:3356985-Kinetics,
pubmed-meshheading:3356985-Male,
pubmed-meshheading:3356985-Rats,
pubmed-meshheading:3356985-Receptors, Adrenergic,
pubmed-meshheading:3356985-Receptors, Serotonin,
pubmed-meshheading:3356985-Serotonin
|
pubmed:year |
1988
|
pubmed:articleTitle |
Serotonergic and adrenergic receptors in alcohol-preferring and non-preferring rats.
|
pubmed:affiliation |
Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|